Krukenberg tumors of colorectal origin: a dismal outcome--experience of a tertiary center.
BACKGROUND
Krukenberg tumor (KT) is described as metastases of the ovary usually from a tumor of gastric origin. As colorectal cancer (CRC) is now the most common cancer in Singapore, we are seeing more KT with colorectal origin.


OBJECTIVE
To determine the pattern of presentation of KT from CRC origin in terms of patient demographics, time of onset related to the diagnosis of CRC, presence of elevated serum tumor markers, carcinomatosis peritoneii, and survival of patients.


METHODS
A retrospective database review of all patients diagnosed with KT from CRC treated in a specialized colorectal surgery department between August 1992 and March 2004.


RESULTS
Twenty-five patients' records were available for analysis. Median age at diagnosis was 53 years old (range: 38-79). Sixteen patients (64%) had ovarian metastasis at the time of diagnosis of the CRC. Eleven patients (44%) had unilateral ovarian involvement. Nineteen patients (76%) had carcinomatosis peritoneii. Serum Carcinoembryonic antigen (CEA) was available for 21 patients, 18 (86%) were raised; serum cancer antigen-125 (CA-125) was available for seven patients, five (71%) were raised. There were 11 mortalities (44%) and all died of the disease. Median time between diagnosis of KT and death was 19 months. The rest of the patients were alive with existence of disease at last follow-up.


CONCLUSIONS
KT is associated with a dismal outcome and poor prognosis. There was 0% disease-free survival. Serum CEA and CA-125 tend to rise in patients with KT. Patients investigated for elevated CA-125 and unilateral ovarian mass should have the diagnosis of colorectal cancer excluded before treatment of ovarian mass.
Tan
Kian-Lee
KL
Department of Colorectal Surgery, Singapore General Hospital, Outram Road, Singapore.
Tan
Wah-Siew
WS
Lim
Jit-Fong
JF
Eu
Kong-Weng
KW
D000230:Adenocarcinoma / Q000276:immunology / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D000328:Adult; D017668:Age of Onset; D000368:Aged; D018394:CA-125 Antigen / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000097:blood; D015179:Colorectal Neoplasms / Q000276:immunology / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007725:Krukenberg Tumor / Q000276:immunology / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000276:immunology / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D010534:Peritoneal Neoplasms / Q000556:secondary; D012189:Retrospective Studies; D012846:Singapore / Q000453:epidemiology; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
D018394:CA-125 Antigen; D002272:Carcinoembryonic Antigen
Gynecol Oncol. 1993 Feb;48(2):148-54
8381375
Br J Surg. 1992 Dec;79(12):1364-6
1336701
J Surg Oncol. 2007 Aug 1;96(2):113-7
17443728
Adv Anat Pathol. 2006 Sep;13(5):205-27
16998315
Hepatogastroenterology. 2004 Sep-Oct;51(59):1350-3
15362750
Prim Care Update Ob Gyns. 1998 Jul 1;5(4):157-158
10838292
Ginekol Pol. 2006 Mar;77(3):203-8
16871838
Chirurgia (Bucur). 2007 Jul-Aug;102(4):407-10
17966936
Ann Pathol. 2000 May;20(3):202-6
10891713
Nihon Sanka Fujinka Gakkai Zasshi. 1981 Jan;33(1):142-50
6164739
Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Mar;10(2):146-8
17380455
Tunis Med. 2007 Sep;85(9):806-10
18254316
Gynecol Oncol. 1997 Sep;66(3):368-71
9299247